Showing results (1-10 of 146) with videos related to
Sort By:
Pageof 15
Current Opinion in Chemical Biology|August 4, 2004
Predictive ADMET studies, the challenges and the opportunitiesAndrew M Davis, Robert J RileyExpert Opinion on Drug Metabolism & Toxicology|November 10, 2017
Hepatic transporter drug-drug interactions: an evaluation of approaches and methodologiesBeth Williamson, Robert J RileyDrug Discovery Today. Technologies|July 2, 2014
Metabolic screening in vitro: metabolic stability, CYP inhibition and inductionRobert J Riley, Ken GrimeDrug Discovery Today|September 26, 2015
A new paradigm for navigating compound property related drug attritionPatrick Barton, Robert J RileyPerspectives in Biology and Medicine|May 3, 2011
Teaching quality and cost in the tumultuous era of health-care reformAndrew M DavisProceedings of the National Academy of Sciences of the United States of America|November 23, 2011
Stardust in meteoritesAndrew M DavisCurrent Opinion in Drug Discovery & Development|February 26, 2004
Cellular models for ADMET predictions and evaluation of drug-drug interactionsRobert J Riley, J Gerry KennaExpert Opinion on Drug Metabolism & Toxicology|February 10, 2015
Cytochrome P450 time-dependent inhibition and induction: advances in assays, risk analysis and modellingRobert J Riley, Claire E WilsonExpert Opinion on Drug Metabolism & Toxicology|February 3, 2007
Time-dependent CYP inhibitionRobert J Riley, Ken Grime, Richard WeaverHeart, Lung & Circulation|November 29, 2011
Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular TachycardiaAndreas Pflaumer, Andrew M DavisPageof 15